Showa Inan General hospital
Komagane, Nagano, 399-4191, Japan
NCT Number: NCT04720781
After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.
Looking for future studies?
Notify Me19 year–100 year
All sexes
Interventional
Not applicable
Komagane, Nagano, 399-4191, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vonoprazan (20mg/day) is prescribed for 4 weeks.
Other names: Esomeprazole
esomeprazole (20mg/day)
Time frame: 3 months
The need to revisit our outpatient clinic again without any appointments may show the patients' satisfaction or dissatisfaction after the prescription of vonoprazan or esomeprazole. The difference in the number between the two groups may show the difference in the effectiveness between the two medicines.
Time frame: 3 months
The ratio of the degree of the main symptom after/before taking the medicine Good 0%- Bad 100%
Time frame: 3months
The patient's satisfaction is assessed using visual analogue scale (Exellent 100% to very bad 0%).
Showa Inan General Hospital
Other
The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole for 4weeks for Erosive Esophagitis Without Any Appointments
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05556824
Deglutition Disorders, Digestive System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03596411
Deglutition Disorders, Digestive System Diseases
Nice, Alpes Maritimes, France
View Trial DetailsNCT02083952
Apnea, Arrhythmias, Cardiac
Ridgewood, New Jersey, United States
View Trial DetailsNCT06329583
Deglutition Disorders, Digestive System Diseases
Jacksonville, Florida, United States
View Trial Details